Secondary analysis of CONFIDENCE (790 adults with type 2 diabetes and CKD): acute eGFR fall at day 14 was larger with empagliflozin plus finerenone (-6.6) than finerenone (-2.1) or empagliflozin (-4.8) alone; AKI was uncommon.
Secondary analysisn = 790
Agarwal et al. Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and Finerenone